![John Bishop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Bishop
Directeur Technique/Scientifique/R&D chez
ARDELYX, INC.
Fortune : 1 M $ au 31/08/2026
Profil
John E.
Bishop is currently Chief Technical & Quality Officer at Ardelyx, Inc. since 2026.
Formerly, Dr. Bishop was Chief Technology Officer at Lyra Therapeutics, Inc. from 2023 to 2024 and at Forma Therapeutics Holdings, Inc. from 2021 to 2023.
Served as Senior Vice President-Pharmaceutical Sciences at Epizyme, Inc. from 2017 to 2021 and as Senior Vice President-Pharmaceutical Sciences at Genocea Biosciences, Inc. from 2016 to 2017.
Held the position of Senior Vice President-Pharmaceutical Services at Momenta Pharmaceuticals, Inc. from 2006 to 2016.
Worked as Director & Head-Process Development at Millennium Pharmaceuticals, Inc. from 2000 to 2004 and as Leader-Process Research & Development at DuPont Merck Pharmaceutical Co. from 1994 to 2000.
Education includes undergraduate studies at Tufts University, an MBA from Northeastern University, and a doctorate from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARDELYX, INC. 0,13 % | 21/08/2026 | 317 095 ( 0,13 % ) | 1 M $ | 31/08/2026 |
Postes actifs de John Bishop
| Sociétés | Poste | Début |
|---|---|---|
| ARDELYX, INC. | Directeur Technique/Scientifique/R&D | 01/01/2026 |
Anciens postes connus de John Bishop
| Sociétés | Poste | Fin |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 20/06/2024 |
| FORMA THERAPEUTICS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2023 |
| EPIZYME, INC. | Corporate Officer/Principal | 01/05/2021 |
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2017 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2016 |
Formation de John Bishop
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
